Glass Health
Ambient scribe plus clinical decision support in one platform.
Overview
Glass Health combines ambient AI scribing with clinical decision support — differential diagnosis, assessment and plan drafting, and clinical Q&A with citations — in one workflow. It offers a free Lite tier and published paid plans, with EHR integration on its top plan.
- +Scribing and clinical decision support in one tool
- +Usable free Lite tier
- +Published pricing
- +Evidence-cited answers
- -Lite and Starter plans are ad-supported
- -Individual terms authorize model training on PHI
- -BAA is opt-in, not automatic
- -EHR integration only on the $200 Max plan
- -Usage caps per plan are not published
Features
Integrations
Articles that cover Glass Health
FDA's Generative AI Device Paper: What It Means for the AI Tools Your Practice Uses (Comments Due Oct. 19)
On August 18, 2026, FDA published its first detailed sketch of how it might regulate generative AI medical devices: a two-axis risk map, clinician-style competency testing, and more postmarket monitoring. It is not guidance and binds no one yet. Here is what it says, where scribes, CDS, patient chatbots and imaging tools land, what the first 'patient-facing LLM' clearance actually covered, and which of the 26 questions clinicians should answer before the October 19 deadline.
NPs Benefit Most From AI Scribes. They Also Carry a Billing Risk Physicians Do Not.
The largest study of ambient AI scribes found advanced practice providers among the biggest beneficiaries. But an NP note also has to establish which billing pathway applies — incident-to, split/shared, or straight 85% — and no scribe writes that for you. With an OIG audit of incident-to payments underway, here is what your note has to say and how to configure your scribe to say it.
Can You Bill for AI? Medicare Already Cut Your Pay for the Efficiency.
The FDA has authorized more than 1,300 AI-enabled medical devices. Medicare pays separately for about ten of them. Meanwhile CMS cut work RVUs 2.5% across most services on the theory that technology already made you more efficient. Here are the AI codes that actually generate payment in 2026, the taxonomy that decides which tools get one, and what the CY 2027 proposed rule would change.
FDA Just Moved the Line Between a Clinical Tool and a Regulated Device
In January 2026, the FDA rewrote its clinical decision support guidance and pushed more AI software outside its oversight. Single recommendations are now allowed, documentation tools got clearer footing, and generative AI got almost no framework at all. Here is what changed — and why 'no FDA clearance needed' tells you nothing about whether a tool works.
The Best Free and Low-Cost AI Medical Scribes for Solo Practitioners in 2026
Solo clinicians shouldn't pay enterprise pricing for AI documentation. We dug into every legitimate free and under-$80/month AI scribe option in 2026 — which ones are genuinely free, which ones are bait, and which ones actually fit a solo practice workflow.